TB-500 (Thymosin Beta-4) · Research brief

TB-500 Supplier: Pricing and Purity Verification

Real Peptides Research TeamEditorial

Updated September 24, 20269 min read

57 WORDS

Short answer

Most procurement failures in peptide research don't happen at the bench. They happen at the purchase order, when a lab buys a vial labelled TB-500 from a TB-500 supplier that has never published a single batch-matched certificate of analysis. The powder looks identical either way. Lyophilised peptide is white, fluffy and completely uninformative to the naked eye.

Key takeaways

TB-500 is a synthetic fragment corresponding to an active region of thymosin beta-4, not the complete 43-amino-acid protein, and the two carry different CAS numbers and molecular weights.
A legitimate TB-500 supplier provides a batch-specific certificate of analysis whose lot number matches the label on the vial you received.
HPLC purity and net peptide content are separate measurements, and only comparing both gives you a valid per-milligram TB-500 price comparison.
Mass spectrometry confirming the theoretical molecular weight is the only practical identity check available to a purchasing lab.
TB-500 reviews reliably indicate shipping and service quality but cannot substantiate purity, identity or potency.
Real Peptides supplies TB-500 as a research-use-only compound with publicly accessible certificates of analysis, and does not provide dosing or preparation guidance of any kind.

Our team has worked with researchers sourcing thymosin beta-4 fragments for years, and the pattern repeats: the labs that get reproducible data are the ones that verified identity and purity documentation before the vial shipped, not after an experiment produced noise.

What should you look for in a TB-500 supplier?

A credible TB-500 supplier provides a batch-specific certificate of analysis with HPLC purity data and mass spectrometry confirmation, states the CAS number and molecular identity openly, and labels the compound research use only. Price alone tells you nothing. Documentation that matches the lot number on your vial tells you everything.

The common oversimplification is that buying peptides is a price comparison exercise. It isn't. TB-500 sold cheaply is often sold cheaply because purity sits lower, net peptide content is unstated, or the COA belongs to a different lot entirely. This piece covers what TB-500 actually is in the published literature, how to read supplier documentation properly, what drives TB-500 price differences, and how to interpret TB-500 reviews.

What the literature actually says about TB-500 and thymosin beta-4

TB-500 is a synthetic peptide corresponding to a short active region of thymosin beta-4 (Tβ4), a naturally occurring 43-amino-acid protein found in most mammalian cells and in high concentration in platelets and wound fluid. It is not the full protein. That distinction matters when you're comparing a TB-500 supplier catalog against a thymosin beta-4 listing, because the two are chemically different products with different molecular weights and different CAS registry numbers.

The mechanism described in the published literature centres on actin. Research reports that thymosin beta-4 functions as the principal G-actin sequestering peptide in mammalian cells, binding monomeric actin and regulating the polymerisation dynamics that drive cell migration, cytoskeletal remodelling and tissue repair processes in preclinical models. Studies also describe effects on angiogenesis and inflammatory signalling in animal and cell-culture work. Human clinical development has been limited, and TB-500 is not an FDA-approved drug product. It has no approved human indication.

The practical takeaway for procurement is that the biological question you're studying depends on a specific sequence being present at a specific purity. If the peptide in the vial is 85% pure with unidentified deletion sequences making up the rest, your actin-binding assay is measuring something you can't name. That's why a serious TB-500 supplier leads with analytical data rather than marketing copy. Our experience across research procurement is consistent: the suppliers who publish the least tend to be the ones whose data least supports publishing.

How to read a certificate of analysis from any TB-500 supplier

A certificate of analysis is only useful if the lot number on the document matches the lot number on your vial. That single check eliminates a large share of questionable vendors immediately, because a generic PDF with no lot identifier is a marketing asset, not an analytical record.

Four data points carry the weight. HPLC purity (high-performance liquid chromatography) separates the target peptide from truncated or deletion byproducts and reports the target as a percentage of total peak area — research-grade material is typically reported at 98% or higher. Mass spectrometry confirms molecular weight, which is your identity check: the observed mass should match the theoretical mass for the sequence. CAS number gives you an independent registry identifier to cross-check the compound you think you're buying. Net peptide content tells you how much of the vial's mass is actually peptide versus residual trifluoroacetic acid (TFA) salt and bound water.

That last one is the detail most guides skip, and it's where price comparisons quietly break down. A lyophilised vial labelled 10mg may contain meaningfully less than 10mg of peptide by mass once TFA counterion and residual moisture are accounted for. Two vendors can both label a product 10mg, both show 98% HPLC purity, and still be selling different quantities of peptide — because purity and net peptide content are different measurements. If a TB-500 supplier reports purity but never reports net peptide content, you cannot compare their TB-500 price to anyone else's on a per-milligram basis. You're comparing labels, not material.

Real Peptides publishes certificates of analysis for its catalog, including TB-500 10mg, so the documentation is verifiable before purchase rather than after.

What actually drives TB-500 price differences between suppliers

TB-500 price varies widely across vendors, and the spread usually reflects real differences in synthesis, purification and testing rather than arbitrary margin. Solid-phase peptide synthesis costs scale with sequence length, coupling efficiency and the number of purification passes required to reach high purity. Each additional preparative HPLC run removes impurities and removes yield at the same time.

Third-party analytical testing adds cost per batch. So does small-batch synthesis, which trades the economics of large runs for tighter lot-to-lot consistency. A TB-500 supplier running small batches with independent testing on every lot carries a structurally higher cost base than a reseller drop-shipping unlabelled bulk material, and the price reflects that.

What to be sceptical of: a TB-500 price dramatically below the market range with no COA, no lot traceability and no stated net peptide content. Cold chain handling is another hidden variable. Lyophilised peptides are stable for extended periods when stored frozen and protected from moisture, but shipping without temperature control or desiccation introduces degradation risk that no price advantage compensates for.

Honest framing on TB-500 reviews: reviews are useful for supplier responsiveness, shipping reliability and packaging quality. They are not evidence of purity. A reviewer cannot assess peptide identity from a photograph of a vial. Treat TB-500 reviews as service data and the certificate of analysis as material data. Our team treats any supplier that markets on reviews while withholding analytical documentation as a supplier that has chosen persuasion over proof.

TB-500 supplier evaluation: documentation tiers compared

The table below compares what different tiers of peptide vendors typically provide, so a researcher can place any TB-500 supplier on the spectrum before committing to a purchase order.

Verification Signal	Unverified Reseller	Mid-Tier Vendor	Documented Research Supplier	Professional Assessment
Certificate of analysis	None, or a generic PDF with no lot number	Provided on request, sometimes lot-matched	Published per batch, lot number matches the vial label	Lot-matched COA is the single highest-value check; treat its absence as disqualifying
HPLC purity reporting	Purity claimed in marketing copy only	Percentage stated without chromatogram	Chromatogram included with retention time and peak area	A number with no chromatogram cannot be independently assessed
Molecular identity	No CAS number or mass spec data	CAS number listed, no mass spec	CAS number plus mass spectrometry confirming theoretical mass	Mass spec is your only proof the sequence is what the label says
Net peptide content	Never stated	Occasionally stated	Reported alongside purity	Without this figure, per-milligram TB-500 price comparisons are meaningless
Regulatory labelling	Vague or implies human use	Research use only in fine print	Research use only stated clearly across product and site	Any human-use framing signals a vendor operating outside the research supply model

What If: TB-500 Supplier Sourcing Scenarios

What if the COA I received has no lot number on it?

Request the lot-matched document before opening the vial. A certificate without a lot identifier cannot be tied to the material in your hands, which means the purity and mass spectrometry data on it describe an unknown batch. Reputable suppliers generate analytical data per synthesis run precisely because lot-to-lot variation exists. If the vendor cannot produce a lot-matched COA within a reasonable window, the material should be treated as uncharacterised for research purposes.

What if two suppliers list 10mg TB-500 at very different prices?

Compare net peptide content and HPLC purity before comparing price. A 10mg label refers to vial fill mass, which includes TFA counterion and residual moisture alongside the peptide itself. Two vials with identical labels can differ meaningfully in actual peptide mass, and that gap alone can account for a price difference that looks like a bargain. Where net peptide content isn't published, the cheaper vial isn't demonstrably cheaper.

What if my TB-500 vial arrived at room temperature?

Document the arrival condition and contact the supplier before use. Lyophilised peptides tolerate short ambient excursions far better than reconstituted solutions, but degradation risk depends on duration, humidity exposure and vial seal integrity — none of which can be assessed visually. Appearance is not a potency indicator. A supplier with proper cold chain and desiccated packaging protocols should be able to tell you the shipping conditions for your specific lot.

The uncomfortable truth about peptide supplier marketing

Here's the honest answer: most of what a TB-500 supplier tells you on a product page is unverifiable, and the industry knows it. Purity percentages without chromatograms, vague gestures at third-party testing, and five-star TB-500 reviews from accounts that never post again are all cheap to produce. Analytical documentation is not cheap to produce. That asymmetry is exactly why documentation is the signal and marketing is the noise. If a vendor invests in publishing per-batch COAs, CAS numbers and mass spec data, they have accepted a cost that a low-quality operation would never voluntarily take on. Judge suppliers by what's expensive for them to fake.

Why Real Peptides publishes documentation before you buy

Research reproducibility depends on knowing what's in the vial, which is why every compound in the Real Peptides catalog is produced through small-batch synthesis with exact amino-acid sequencing and backed by accessible analytical records. Researchers evaluating a TB-500 supplier can review the TB-500 research overview, examine batch certificates directly, and browse the full peptide catalog or the supplier information page before committing to any purchase.

One boundary worth stating plainly: Real Peptides does not provide dosing, reconstitution or administration guidance for any catalog compound, because every product is supplied for laboratory research use only and is not an FDA-approved drug. What we do provide is the concentration framework researchers need for their own documentation — the milligram content of the vial as stated on the certificate of analysis, expressed in milligrams per millilitre once a laboratory has defined its own experimental parameters. That's the ceiling, and it's deliberate. Determining study parameters is the investigator's responsibility, informed by the published literature and institutional protocols, not a supplier's marketing department.

A TB-500 supplier that answers protocol questions is telling you something about how it views regulatory boundaries. A TB-500 supplier that answers analytical questions in detail is telling you something about its synthesis.

The peptide research market rewards whichever vendor tells the most confident story, which is precisely backwards. Confidence is free. A chromatogram tied to the lot number printed on your vial costs money to generate and is nearly impossible to fabricate convincingly. Before your next order from any TB-500 supplier, ask for that one document — and notice how much you learn from how quickly, or whether, it arrives.

References

Peer-reviewed sources on TB-500 (Thymosin Beta-4) indexed in PubMed, listed for research context. Real Peptides supplies TB-500 (Thymosin Beta-4) for laboratory research use only.

Thymosin β4 alleviates sepsis-associated acute kidney injury by suppressing MAPK signaling pathway. Clinical science (London, England : 1979), 2026. PMID 42417058. doi:10.1042/CS20261084
Sprayable bioadhesive microcarriers loaded with Tβ4-Engineered ADSC exosomes for diabetic wound healing. Bioactive materials, 2026. PMID 42383202. doi:10.1016/j.bioactmat.2026.06.024
Thymosin beta 4 as an Alzheimer disease intervention target identified using human brain organoids. Stem cell reports, 2025. PMID 40816274. doi:10.1016/j.stemcr.2025.102601
Mechanistic study of the Tβ4/SLC7A11 signaling pathway regulating breast cancer evolution. Cellular signalling, 2025. PMID 40912522. doi:10.1016/j.cellsig.2025.112111
Thymosin β4 Regulates Tissue Inflammatory Response in Mouse Nonalcoholic Fatty Liver Disease by Promoting Macrophage M2-Type Polarization. Journal of inflammation research, 2025. PMID 40322536. doi:10.2147/JIR.S492814
Injectable Thymosin β4-Modified Hyaluronic Acid Hydrogel with Exosomes for Stem Cell Homing and Neuronic-Angiogenic-Osteogenic Coupled Cranial Repair. ACS nano, 2025. PMID 40528381. doi:10.1021/acsnano.4c10386
Secreted Expression of Thymosin β4 from Pinctada fucata in Pichia pastoris and Its Biological Activity. Biology, 2025. PMID 40427742. doi:10.3390/biology14050553
Thymosin β4 and the anti-fibrotic switch. International immunopharmacology, 2023. PMID 36580759. doi:10.1016/j.intimp.2022.109628

Questions

Look for a batch-specific certificate of analysis whose lot number matches the vial label, HPLC purity data presented with an actual chromatogram, mass spectrometry confirming the theoretical molecular weight, a stated CAS number, and clear research-use-only labelling. Net peptide content should also be published, since it determines how much peptide the vial actually contains beyond TFA salt and residual moisture. A supplier that provides all five is demonstrably investing in analytical verification rather than marketing claims.

TB-500 is a synthetic peptide corresponding to a short active region of thymosin beta-4, a naturally occurring 43-amino-acid protein present in most mammalian cells and concentrated in platelets and wound fluid. They are not interchangeable: the fragment and the full protein have different molecular weights and different CAS registry numbers. Research describes thymosin beta-4 as the principal G-actin sequestering peptide involved in cytoskeletal remodelling and cell migration in preclinical models.

TB-500 price differences generally reflect synthesis and purification depth, the number of preparative HPLC passes required to reach high purity, batch size, and whether independent third-party testing is run on every lot. Small-batch synthesis with per-lot analytical testing carries a higher structural cost than reselling unlabelled bulk material. A price far below the market range with no lot-matched certificate of analysis and no stated net peptide content is a signal worth investigating rather than a bargain.

TB-500 reviews are useful for assessing shipping speed, packaging quality, customer service responsiveness and order accuracy. They cannot assess purity, peptide identity or potency, because no reviewer can determine molecular identity from handling a vial. Use reviews as service data and the batch certificate of analysis as material data, and be cautious of any vendor that markets heavily on reviews while withholding analytical documentation.

Real Peptides does not provide dosing, reconstitution, administration or protocol guidance for any catalog compound, because all products are supplied for laboratory research use only and are not FDA-approved drugs. What a supplier can legitimately provide is the analytical record: the milligram content of the vial, purity, net peptide content and molecular identity. Determining study parameters is the responsibility of the investigating laboratory under its own institutional protocols.

Cross-check three things against the batch certificate of analysis: the lot number printed on the vial, the CAS number for the compound, and the mass spectrometry result confirming the observed molecular weight matches the theoretical mass for the sequence. Mass spectrometry is the only practical identity confirmation available to a purchasing laboratory. Visual inspection of lyophilised powder tells you nothing, since research-grade and substandard material look identical.

No. TB-500 is not an FDA-approved drug product and has no approved human indication. It is supplied as a research chemical for laboratory use only and is not intended for human or veterinary consumption. Human clinical development of thymosin beta-4 fragments has been limited, and most published work describing actin-binding and tissue-repair mechanisms comes from cell-culture and animal models.

High-performance liquid chromatography separates the target peptide from truncated sequences, deletion byproducts and other synthesis impurities, then reports the target peak as a percentage of total peak area. A 98% figure means 98% of the detected peak area corresponds to the intended sequence. It does not tell you how much of the vial's total mass is peptide, which is a separate measurement called net peptide content.

Lyophilised peptides are generally most stable when kept frozen, protected from light and held in a desiccated environment, since moisture uptake is the primary degradation pathway for freeze-dried material. Suppliers should state recommended storage conditions on the product documentation and certificate of analysis. Appearance is not a stability indicator, so any temperature or humidity excursion during transit should be documented and raised with the supplier.

A TB-500 manufacturer performs the solid-phase peptide synthesis and purification itself and therefore controls sequence accuracy, purification passes and per-batch testing. A reseller purchases finished or bulk material and repackages it, which means analytical records may originate upstream and may not be lot-matched to what ships to you. The practical test is whether the vendor can supply a certificate tied to your specific lot number rather than a generic document.

Not automatically, but it usually means something specific is different, and you should identify what. Lower purity, larger batch sizes, absent third-party testing, higher residual TFA salt content or reduced cold chain handling all reduce cost. If a supplier publishes both HPLC purity and net peptide content, you can compare on a true per-milligram basis; if either figure is missing, the comparison is between labels rather than between materials.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA